MyFinsight
Home
Blog
About
Contact
Download
Download image
Investment securities,
available-for-sale
$641,991K
Cash and cash
equivalents
$177,695K
Accounts receivable, net
$121,457K
Prepaid expenses
$59,526K
Inventory
$34,670K
Interest and other
receivables
$26,774K
Property and equipment,
gross
$16,995K
Total current assets
$1,062,113K
Deferred tax assets
$249,879K
Intangible assets, net
$108,893K
Long-term inventory
$76,704K
Operating lease
right-of-use assets
$47,354K
Restricted cash
$7,845K
Property and equipment,
net
$7,511K
Other assets
$3,896K
Accumulated depreciation
$9,484K
Total assets
$1,564,195K
Total liabilities and
stockholders equity
$1,564,195K
Total stockholders
equity
$1,227,390K
Total liabilities
$336,805K
Accumulated deficit
-$1,813,386K
Additional paid-in capital
$3,039,315K
Total current
liabilities
$277,114K
Operating lease
liabilities
$40,554K
Other long-term
liabilities
$19,137K
Accumulated other
comprehensive income
$1,445K
Common stock, 0.0001
par value...
$16K
Accrued liabilities
$266,211K
Accounts payable
$10,903K
Back
Back
Balance Sheet
source: myfinsight.com
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)